158 related articles for article (PubMed ID: 23470844)
41. Microenvironment-evoked cell lineage conversion: Shifting the focus from internal reprogramming to external forcing.
Lin J; Li MR; Ti DD; Chen MX; Hao HJ; Zhao YL; Fu XB; Han WD
Ageing Res Rev; 2013 Jan; 12(1):29-38. PubMed ID: 22561469
[TBL] [Abstract][Full Text] [Related]
42. 10th anniversary of iPS cells: the challenges that lie ahead.
Aoi T
J Biochem; 2016 Sep; 160(3):121-9. PubMed ID: 27387749
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of Musculoskeletal Systems and Their Diseases. Use of iPS cells in regenerative therapy and drug discovery for cartilage diseases].
Tsumaki N
Clin Calcium; 2015 Aug; 25(8):1162-8. PubMed ID: 26224673
[TBL] [Abstract][Full Text] [Related]
44. Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.
Carpenter MK; Couture LA
Regen Med; 2010 Jul; 5(4):569-79. PubMed ID: 20632860
[TBL] [Abstract][Full Text] [Related]
45. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
[TBL] [Abstract][Full Text] [Related]
46. Induced pluripotent stem cell-based therapies for inherited arrhythmias: opportunities and challenges involved (Review).
Li G; He X; Sun C
Mol Med Rep; 2015 Jan; 11(1):3-10. PubMed ID: 25323841
[TBL] [Abstract][Full Text] [Related]
47. Induced pluripotent stem cells (iPSc) for gene therapy.
Szabłowska-Gadomska I; Górska A; Małecki M
Med Wieku Rozwoj; 2013; 17(3):191-5. PubMed ID: 24296442
[TBL] [Abstract][Full Text] [Related]
48. Human iPS cell-based therapy: considerations before clinical applications.
Sun N; Longaker MT; Wu JC
Cell Cycle; 2010 Mar; 9(5):880-5. PubMed ID: 20160515
[TBL] [Abstract][Full Text] [Related]
49. Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine.
Ebben JD; Zorniak M; Clark PA; Kuo JS
World Neurosurg; 2011; 76(3-4):270-5. PubMed ID: 21986423
[TBL] [Abstract][Full Text] [Related]
50. Current status and future directions of clinical applications using iPS cells-focus on Japan.
Tsujimoto H; Osafune K
FEBS J; 2022 Dec; 289(23):7274-7291. PubMed ID: 34407307
[TBL] [Abstract][Full Text] [Related]
51. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.
Watmuff B; Liu B; Karmacharya R
Pharmacogenomics; 2017 Apr; 18(5):471-479. PubMed ID: 28346060
[TBL] [Abstract][Full Text] [Related]
52. Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications.
Goodridge HS
Drug Discov Today; 2014 Jun; 19(6):774-80. PubMed ID: 24445266
[TBL] [Abstract][Full Text] [Related]
53. Biophysical regulation of cell reprogramming.
Wong SY; Soto J; Li S
Curr Opin Chem Eng; 2017 Feb; 15():95-101. PubMed ID: 28413770
[TBL] [Abstract][Full Text] [Related]
54. iPS cell technology: Future impact on renal care.
Freedman BS; Steinman TI
Nephrol News Issues; 2015 Aug; 29(9):18, 20-1. PubMed ID: 26454909
[TBL] [Abstract][Full Text] [Related]
55. iPS cell therapy reported safe.
Normile D
Science; 2017 Mar; 355(6330):1109-1110. PubMed ID: 28302802
[No Abstract] [Full Text] [Related]
56. iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review.
Csobonyeiova M; Polak S; Zamborsky R; Danisovic L
J Adv Res; 2017 Jul; 8(4):321-327. PubMed ID: 28386481
[TBL] [Abstract][Full Text] [Related]
57. Potential of transposon-mediated cellular reprogramming towards cell-based therapies.
Kumar D; Anand T; Talluri TR; Kues WA
World J Stem Cells; 2020 Jul; 12(7):527-544. PubMed ID: 32843912
[TBL] [Abstract][Full Text] [Related]
58. Induced pluripotent stem cells: A new addition to the virologists armamentarium.
Kuadkitkan A; Wikan N; Smith DR
J Virol Methods; 2016 Sep; 235():191-195. PubMed ID: 27544025
[TBL] [Abstract][Full Text] [Related]
59. Stem cells: will they ever be the same?
Pryzhkova MV
Regen Med; 2013 Mar; 8(2):97-9. PubMed ID: 23477389
[No Abstract] [Full Text] [Related]
60. Induced pluripotent stem cells: current progress and future perspectives. Preface.
Zhou Q
Genomics Proteomics Bioinformatics; 2013 Oct; 11(5):257-8. PubMed ID: 24121127
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
